Aeglea BioTherapeutics
peace phase study design | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
37 of 39
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
May 2023
peace phase study design | Aeglea BioTherapeutics
Investor Presentation
April 2023
peace phase study design | Aeglea BioTherapeutics
Investor Presentation
February 2022
peace phase study design | Aeglea BioTherapeutics
Results
December 2021
peace phase study design | Aeglea BioTherapeutics
Related slides by other companies
Nuvectis Pharma
Investor Presentation
August 2023
phase underway fast track designation | Nuvectis Pharma
AstraZeneca
Investor Event
June 2023
phase trial design | AstraZeneca
Zegna
Results
April 2023
key financial highlights for fiscal year ended robust results in line with strategic plan revenues million yoy yoy excluding adjusted million adjusted margin profit million cash surplus million margin surplus | Zegna
Exscientia
Investor Day
January 2024
enabling studies complete | Exscientia
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io